386 related articles for article (PubMed ID: 19155469)
1. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.
Chauhan SK; El Annan J; Ecoiffier T; Goyal S; Zhang Q; Saban DR; Dana R
J Immunol; 2009 Feb; 182(3):1247-52. PubMed ID: 19155469
[TBL] [Abstract][Full Text] [Related]
2. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells.
Stummvoll GH; DiPaolo RJ; Huter EN; Davidson TS; Glass D; Ward JM; Shevach EM
J Immunol; 2008 Aug; 181(3):1908-16. PubMed ID: 18641328
[TBL] [Abstract][Full Text] [Related]
3. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
4. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
[TBL] [Abstract][Full Text] [Related]
6. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.
Chen Y; Chauhan SK; Lee HS; Stevenson W; Schaumburg CS; Sadrai Z; Saban DR; Kodati S; Stern ME; Dana R
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2457-64. PubMed ID: 23482465
[TBL] [Abstract][Full Text] [Related]
7. Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor.
Taketani Y; Marmalidou A; Dohlman TH; Singh RB; Amouzegar A; Chauhan SK; Chen Y; Dana R
Am J Pathol; 2020 Sep; 190(9):1859-1866. PubMed ID: 32473919
[TBL] [Abstract][Full Text] [Related]
8. Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.
Gao Y; Min K; Zhang Y; Su J; Greenwood M; Gronert K
J Immunol; 2015 Oct; 195(7):3086-99. PubMed ID: 26324767
[TBL] [Abstract][Full Text] [Related]
9. Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation.
Yu M; Lee SM; Lee H; Amouzegar A; Nakao T; Chen Y; Dana R
Am J Pathol; 2020 Jan; 190(1):125-133. PubMed ID: 31669306
[TBL] [Abstract][Full Text] [Related]
10. Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease.
Surico PL; Lee S; Singh RB; Naderi A; Bhullar S; Blanco T; Chen Y; Dana R
Exp Eye Res; 2024 May; 242():109871. PubMed ID: 38527580
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: CTLA-4--B7 interaction suppresses Th17 cell differentiation.
Ying H; Yang L; Qiao G; Li Z; Zhang L; Yin F; Xie D; Zhang J
J Immunol; 2010 Aug; 185(3):1375-8. PubMed ID: 20601598
[TBL] [Abstract][Full Text] [Related]
13. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.
Piconese S; Gri G; Tripodo C; Musio S; Gorzanelli A; Frossi B; Pedotti R; Pucillo CE; Colombo MP
Blood; 2009 Sep; 114(13):2639-48. PubMed ID: 19643985
[TBL] [Abstract][Full Text] [Related]
14. IL-6: regulator of Treg/Th17 balance.
Kimura A; Kishimoto T
Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
[TBL] [Abstract][Full Text] [Related]
15. The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease.
Chen Y; Shao C; Fan NW; Nakao T; Amouzegar A; Chauhan SK; Dana R
Mucosal Immunol; 2021 Jan; 14(1):177-186. PubMed ID: 32327706
[TBL] [Abstract][Full Text] [Related]
16. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells.
Crome SQ; Clive B; Wang AY; Kang CY; Chow V; Yu J; Lai A; Ghahary A; Broady R; Levings MK
J Immunol; 2010 Sep; 185(6):3199-208. PubMed ID: 20720207
[TBL] [Abstract][Full Text] [Related]
18. Dietary DHA amplifies LXA
Gao Y; Su J; Zhang Y; Chan A; Sin JH; Wu D; Min K; Gronert K
Mucosal Immunol; 2018 Nov; 11(6):1674-1683. PubMed ID: 30104626
[TBL] [Abstract][Full Text] [Related]
19. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.
Ratay ML; Glowacki AJ; Balmert SC; Acharya AP; Polat J; Andrews LP; Fedorchak MV; Schuman JS; Vignali DAA; Little SR
J Control Release; 2017 Jul; 258():208-217. PubMed ID: 28501670
[TBL] [Abstract][Full Text] [Related]
20. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection.
Vokaer B; Van Rompaey N; Lemaître PH; Lhommé F; Kubjak C; Benghiat FS; Iwakura Y; Petein M; Field KA; Goldman M; Le Moine A; Charbonnier LM
J Immunol; 2010 Sep; 185(6):3417-25. PubMed ID: 20733201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
